09 Mar '17, 11am

First mass produced graphene based biosensor claimed

First mass produced graphene based biosensor claimed

Called the AGILE R100, the benchtop device is designed to provide biophysical data to pharmaceutical and biotherapeutics companies seeking more informed decisions earlier in the drug discovery process. “Rogue Valley Microdevices has been a true partner in developing a viable large-scale fabrication process for our AGILE biosensor chips,” said Nanomedical Diagnostics’ CEO Ross Bundy. “The ability to manufacture graphene biosensors at scale will enable us to create significant cost reductions for many life science and healthcare applications, as well as introduce game-changing capabilities that have never been seen before.” The graphene biosensor supports Nanomedical’s Field Effect Biosensing (FEB) technology. FEB is an electrical technique which measures the current across the biosensor in which targets are immobilised. Any interaction or binding that occurs on the surface ...

Full article: http://www.newelectronics.co.uk/electronics-news/graphene...

Tweets

When Will Bitcoin Achieve Mass Adoption And Is ...

cointelegraph.com 07 Mar '17, 5pm

Mass adoption is a frequent topic of discussion among the members of the Bitcoin community. There is virtually no disagree...

Building a 'smart city' starts with mass transi...

metro-magazine.com 07 Mar '17, 5pm

This enables private and public entities to engage with people in real-time while they’re riding on a train or waiting at ...

Only Mass Mobilization Can Save the EPA

Only Mass Mobilization Can Save the EPA

350.org 07 Mar '17, 7pm

Only Mass Mobilization Can Save the EPA It’s not yet halfway through Trump’s first 100 days in office and his administrati...